Priyanka Shivdasani
Overview
Explore the profile of Priyanka Shivdasani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
1128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Forrest S, Gupta H, Ward A, Li Y, Doan D, Al-Ibraheemi A, et al.
Nat Commun
. 2024 Aug;
15(1):7218.
PMID: 39174503
No abstract available.
2.
Forrest S, Gupta H, Ward A, Li Y, Doan D, Al-Ibraheemi A, et al.
Nat Commun
. 2024 Jul;
15(1):5837.
PMID: 38992034
To inform clinical trial design and real-world precision pediatric oncology practice, we classified diagnoses, assessed the landscape of mutations, and identified genomic variants matching trials in a large unselected institutional...
3.
Manning D, Shivdasani P, Koeller D, Schwartz A, Rana H, Garber J, et al.
Data Brief
. 2021 Dec;
39:107653.
PMID: 34934780
Von Hippel-Lindau (VHL) syndrome is a hereditary cancer genetic condition associated with inactivating pathogenic alterations in the tumor suppressor gene located at 3p (short arm of chromosome 3). Classic features...
4.
Kundra R, Zhang H, Sheridan R, Sirintrapun S, Wang A, Ochoa A, et al.
JCO Clin Cancer Inform
. 2021 Feb;
5:221-230.
PMID: 33625877
Purpose: Cancer classification is foundational for patient care and oncology research. Systems such as International Classification of Diseases for Oncology (ICD-O), Systematized Nomenclature of Medicine Clinical Terms (SNOMED-CT), and National...
5.
Sands J, Nguyen T, Shivdasani P, Sacher A, Cheng M, Alden R, et al.
Lung Cancer
. 2019 Dec;
140:35-41.
PMID: 31855703
Objectives: Potentially targetable genomic alterations have been identified in lung squamous cell carcinoma (LUSC), but none have yet translated into effective therapy. We examined potential benefits of next generation sequencing...
6.
Hanna G, Kacew A, Chau N, Shivdasani P, Lorch J, Uppaluri R, et al.
JCI Insight
. 2018 Sep;
3(17).
PMID: 30185662
While it has been recognized that human papillomavirus-associated (HPV-associated) oropharyngeal cancer (OPC) portends an improved prognosis, distinct patterns of disease recurrence have emerged. Molecular characterization of this subset of HPV...
7.
Hanna G, Lizotte P, Cavanaugh M, Kuo F, Shivdasani P, Frieden A, et al.
JCI Insight
. 2018 Feb;
3(4).
PMID: 29467336
Programmed cell death protein 1 (PD-1) inhibitors have efficacy in treating squamous cell carcinoma of the head and neck (SCCHN), but objective response rates are low. PD-1 ligand (PD-L1) expression...
8.
Garcia E, Minkovsky A, Jia Y, Ducar M, Shivdasani P, Gong X, et al.
Arch Pathol Lab Med
. 2017 May;
141(6):751-758.
PMID: 28557599
Context: - The analysis of somatic mutations across multiple genes in cancer specimens may be used to aid clinical decision making. The analytical validation of targeted next-generation sequencing panels is...
9.
Paulson V, Shivdasani P, Angell T, Cibas E, Krane J, Lindeman N, et al.
Thyroid
. 2017 Jan;
27(4):506-511.
PMID: 28114855
Background: Molecular testing of thyroid nodules is increasingly being utilized to guide clinical management decisions. RAS mutations are the most frequent mutations detected in the context of an indeterminate fine-needle...
10.
Sholl L, Do K, Shivdasani P, Cerami E, Dubuc A, Kuo F, et al.
JCI Insight
. 2016 Nov;
1(19):e87062.
PMID: 27882345
Comprehensive genomic profiling of a patient's cancer can be used to diagnose, monitor, and recommend treatment. Clinical implementation of tumor profiling in an enterprise-wide, unselected cancer patient population has yet...